Audiological Devices Market to Thrive at a CAGR of 5.3% by 2032: Fact.MR

Audiological devices market which is currently valued at USD 9.53 billion, will expand at a CAGR of 7.1% and reach USD 18.93 billion by 2032.

The growing demand for inexpensive goods, technological advancements like wireless devices, and the growing acceptance of such technologically advanced goods are additional factors influencing product demand for audiology devices. The prevalence of illnesses like Meniere's disease, which affect hearing, is also anticipated to rise, which is anticipated to fuel market expansion.

Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4444?AS

Prominent Audiological Devices Service Players

• William Demant Holding A/S
• GN Store Nord A/S
• Sonova
• WIDEX A/S
• Sivantos Pte. Ltd.

Key Statistics Supporting the Surge

• The digital technology sector accounted for more than 92.6% of the total revenue on the global market for audiology devices.
• The adult market, which also received the largest revenue share, dominated the sector.
• North America dominated the global market for audiology devices, accounting for more than 41.55% of all sales.
• The fastest CAGR is predicted for the Asia Pacific region.
• 19% of the total revenue came from the Indian market.
• During the forecast period, the European market for audiology devices is anticipated to expand at a CAGR of 4.6%.
• Hearing aids accounted for a market share of more than 64% of total revenue for audiology devices.
• The BAHA/BAHS segment is anticipated to grow the market for audiology devices.
• With a revenue share of more than 74%, retail establishments dominated the market for audiology equipment.
• Over the forecast years, the e-commerce segment is expected to grow at the fastest rate.
Recent Development
• Acquisition
A subsidiary of Demant A/S, Oticon Medical, was purchased by Cochlear Ltd. in April 2021. The deal, which cost USD 170 million, will help Cochlear Ltd. grow its clientele by adding 75,000 Oticon Medical hearing aid users.
• Product Launch
In October 2021, the health technology company Audibel unveiled the Arc-AI hearing aid. It is programmed to automatically adjust hearing volume and comes in a variety of designs, including behind-the-ear and fully in-canal styles.
In January 2019, Lively introduced an online audiology platform that provides all customers with hearing aids, exams, and round-the-clock online support. All platform users can communicate with an audiologist via video conference and purchase hearing aids without needing to visit a clinic or retail location.

In August 2019, Oticon unveiled two new digital hearing aids: the Oticon Xceed power hearing aid and the Oticon Xceed Play paediatric hearing aid. It is run on the Velox S platform and uses Oticon BrainHearing technology. the Opensound Optimizer and Opensound Navigator

Competitive Landscape

Prominent players in the Audiological Devices Industry are taking advantage of the rapidly increasing demand for the Audiological Devices in various applications. To further their outreach, players are relying on collaborations, partnerships and acquisitions with existing small, medium and large-scale vendors. Some prominent market developments are as follows :

• In August 2022, GN declared to introduce the Jabra Enhance Plus, a little true wireless earbud that offers a 3-in-1 experience of calls, music, and hearing enhancement.
• In April 2022, for its brand, Signia, WS Audiology A/S received an iF Design award. For the third time, Signia received the prize owing to their Insio Charge & Go AX hearing aids. It is renowned for its comfort and discrete shape, contactless charging, and direct streaming from Android and iOS.
• In February 2021, Cochlear Limited announced it is partnering with leading hearing health experts to conduct the largest ever international clinical study of an investigational cochlear implant that releases a glucocorticoid (anti-inflammatory) drug therapy directly to the cochlea. The CI-DEX Study is a pivotal, prospective, multi-centre, randomised, blinded study evaluating the effect of a glucocorticoid releasing cochlear implant in up to 120 adults in Australia and the United States with moderate to profound sensorineural hearing loss.

Industry Survey

• By Product :

o Hearing Aids
o In-the-ear Hearing Aids (ITE)
o Receiver-in-the-ear Hearing Aids (RITE)
o Behind-the-ear Hearing Aids (BTE)
o Canal Hearing Aids (CHA)
o Cochlear Implants
o Bone-anchored Healing Aids
o Diagnostic Devices:
 Audiometers
 Octoscopes
 Tympanometers

• By Disease Type :

o Otosclerosis
o Meniere's Disease
o Acoustic Tumors
o Otitis Media
o Others

• By End-User :

o Hospitals
o Ambulatory Surgical Centers
o Clinics

• By Region :

o North America
o Europe
o Asia Pacific
o Latin America
o Middle East & Africa

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4444?AS

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Email : sales@factmr.com

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets. We understand that making sense of the vast labyrinth of data can be overwhelming for businesses. That's why focus on offering insights that can actually make a difference to bottom-lines.

This release was published on openPR.